A Novel Standard for Hepatocellular Carcinoma Screening Intensity After Hepatitis C Elimination.

Miyasaka, Akio; Yoshida, Yuichi; Suzuki, Akiko; Sawara, Kei; Takikawa, Yasuhiro

Miyasaka, Akio; Yoshida, Yuichi; Suzuki, Akiko; Sawara, Kei; Takikawa, Yasuhiro.

Afiliação

Miyasaka A; Division of Hepatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Shiwa-gun, Iwate, Japan.
Yoshida Y; Department of Gastroenterology, Iwate Prefectural Ninohe Hospital, Ninohe, Iwate, Japan.
Suzuki A; Division of Hepatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Shiwa-gun, Iwate, Japan.
Sawara K; Department of Gastroenterology, Iwate Prefectural Ninohe Hospital, Ninohe, Iwate, Japan.
Takikawa Y; Division of Hepatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Shiwa-gun, Iwate, Japan.

Int J Gen Med ; 14: 8935-8943, 2021.

Article em En | MEDLINE | ID: mdl-34866934

Palavras-chave

antiviral agents; hepatocellular carcinoma; sustained virological response

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Int J Gen Med Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google